1JKH | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) |
1JLA | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 |
1JLB | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1JLE | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE |
1JLG | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1JLQ | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94 |
1KLM | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152 |
1LW0 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1LW2 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91 |
1LWC | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1LWE | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE |
1LWF | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE |
1REV | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE |
1RT1 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442 |
1RT2 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651 |
1RT3 | B:238-307; B:238-307 | AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91 |
1RT5 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 |
1RT6 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 |
1RT7 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 |
1RTH | B:238-307; B:238-307 | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
1RTJ | B:238-307; B:238-307 | MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS |
1S1T | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1S1U | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1S1W | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 |
1S1X | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE |
1T05 | B:238-307 | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE |
1TKT | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318 |
1TKX | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745 |
1TL1 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211 |
1TL3 | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557 |
1VRU | B:238-307; B:238-307 | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES |
2OPP | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
2OPQ | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
2OPR | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
2OPS | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X. |
2RF2 | B:238-307; B:238-307 | HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI) |
2RKI | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI |
2WOM | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N). |
2WON | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE). |
3KJV | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA |
3KK1 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS-9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE |
3KK2 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE |
3KK3 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER |
3LAK | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAL | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAM | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LAN | B:238-307; B:238-307 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR |
3LP0 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3LP1 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3LP2 | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR |
3M8P | B:238-307; B:238-307 | HIV-1 RT WITH NNRTI TMC-125 |
3MEC | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125 |
3MED | B:238-307; B:238-307 | HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125 |
3MEE | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278 |
3MEG | B:238-307; B:238-307 | HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278 |
3NBP | B:238-307; B:238-307 | HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2 |
3QIP | B:238-307; B:238-307 | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE |